Victoria Tarabanova, country manager of the Ukrainian office of Wörwag Pharma, a company dedicated to treating diabetic comorbidities such as neuropathic, cardiovascular and neurological diseases, provides insights into the company’s remarkable efforts to enhance Ukraine’s health ecosystem and its enduring commitment to Ukrainian patients and physicians – even during the heights of the 2013 crisis.
You have been heading the development of Wörwag Pharma’s representative office in Ukraine since its beginnings in 2003. Could you walk us through its main milestones?
"Although the crisis entailed the loss of a third of our local revenues, Wörwag Pharma did not reconsider its commitment to Ukrainian patients or abandon the market – far from it!"
